CN Stock MarketDetailed Quotes

Honz Pharmaceutical (300086)

Watchlist
  • 7.19
  • -0.30-4.01%
Post Market May 20 15:00 CST
3.27BMarket Cap-14.10P/E (TTM)

Honz Pharmaceutical (300086) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
-81.42%17.27M
-47.21%59.75M
-85.48%17.95M
-52.89%47.46M
-18.66%92.97M
-21.62%113.19M
18.14%123.63M
-41.29%100.73M
-36.34%114.29M
-46.48%144.4M
Notes receivable and accounts receivable
-32.44%41.88M
-35.79%44.16M
-23.27%49.71M
-13.39%60.95M
-43.47%61.98M
-36.07%68.77M
40.89%64.78M
16.52%70.37M
94.07%109.66M
47.09%107.58M
-Notes receivable
-80.87%1.35M
1,092.66%7.39M
175.71%3.11M
3.81%6.27M
-21.32%7.05M
-83.50%620.03K
253.53%1.13M
-31.21%6.04M
39.85%8.96M
87.04%3.76M
-Accounts receivable
-26.22%40.53M
-46.05%36.77M
-26.79%46.6M
-15.00%54.68M
-45.45%54.93M
-34.36%68.15M
39.41%63.66M
24.63%64.33M
101.01%100.69M
45.96%103.82M
Other receivables (including interest and dividends)
-84.44%10.72M
-72.44%11.63M
-54.89%28.27M
-51.82%27.87M
8.35%68.86M
-23.89%42.21M
-4.92%62.65M
0.94%57.84M
-6.27%63.56M
-18.00%55.46M
-Other receivable
----
-72.44%11.63M
----
----
----
-23.89%42.21M
----
0.94%57.84M
----
-18.00%55.46M
Advance payment
3.28%36.55M
12.74%26.85M
-2.49%42.99M
-17.33%28.8M
-5.95%35.39M
-15.26%23.81M
17.90%44.09M
-12.65%34.84M
-3.23%37.63M
-68.32%28.1M
Inventories
-8.61%160.33M
-14.53%160.12M
-24.62%166.89M
-31.55%167.85M
-27.17%175.43M
-20.77%187.33M
-16.17%221.41M
-1.15%245.22M
8.16%240.87M
38.75%236.43M
Other current assets
-61.35%2.06M
-73.66%1.97M
-22.95%4.46M
-45.70%3.38M
74.75%5.33M
40.25%7.47M
-25.12%5.78M
133.24%6.23M
-1.91%3.05M
593.00%5.33M
Total current assets
-38.90%268.81M
-31.24%304.48M
-40.60%310.26M
-34.73%336.3M
-22.68%439.97M
-23.30%442.78M
-0.65%522.35M
-11.15%515.22M
0.09%569.05M
-13.90%577.3M
Non Current assets
Other equity investment
0.00%4.97M
0.00%4.97M
-6.16%4.97M
-6.16%4.97M
-6.16%4.97M
-6.16%4.97M
-10.87%5.3M
-10.87%5.3M
-10.87%5.3M
-10.87%5.3M
Investment real estate
128.76%556.07M
169.58%556.07M
149.93%564.86M
7.56%243.08M
7.56%243.08M
-8.73%206.27M
-4.88%226.01M
-4.88%226.01M
-4.88%226.01M
-4.88%226.01M
Fixed assets
----
-31.46%680.02M
----
----
----
17.88%992.13M
----
-1.81%847.79M
----
-5.53%841.67M
Fixed assets liquidation
----
----
----
----
----
207.16%85.69K
----
--27.9K
----
--27.9K
Constru in process
----
49.61%18M
----
----
----
-91.74%12.03M
----
63.55%146.29M
----
144.37%145.62M
Productive biological assets
----
----
----
----
--17.18K
----
--21.78K
--17.16K
----
----
Intangible assets
-58.29%61.6M
-54.45%63.71M
-34.49%101.85M
-7.61%145.83M
-6.55%147.7M
-12.77%139.86M
-3.48%155.47M
-3.20%157.84M
-4.36%158.06M
-4.31%160.33M
Development expenditure
-39.03%31.07M
-39.03%31.07M
18.66%55.6M
14.27%53.54M
16.71%50.97M
16.79%50.97M
22.86%46.86M
22.86%46.86M
14.50%43.67M
16.85%43.64M
Goodwill
-38.52%8.3M
-38.52%8.3M
-34.55%13.5M
-34.55%13.5M
-32.68%13.5M
-32.68%13.5M
9.19%20.63M
9.19%20.63M
6.14%20.05M
6.14%20.05M
Long deferred expense
-18.81%25.06M
-7.83%24.79M
-11.08%26.32M
-11.77%28.54M
-18.84%30.87M
-28.04%26.9M
-16.97%29.6M
-13.87%32.35M
-1.96%38.03M
-1.26%37.38M
Deferred tax assets
26.77%64.93M
37.14%70.74M
9.79%65.15M
-1.84%56.97M
18.10%51.22M
2.48%51.59M
35.55%59.35M
17.97%58.04M
-8.96%43.37M
5.08%50.34M
Usufruct assets
-5.41%16.91M
-5.33%17.15M
--17.39M
--17.63M
--17.87M
--18.11M
----
----
----
----
Other non current assets
-24.69%11.4M
-32.43%11.68M
-46.77%14.34M
-33.06%19.82M
-73.48%15.14M
-49.06%17.29M
-30.70%26.95M
-52.19%29.61M
-37.08%57.09M
-70.32%33.95M
Total non current assets
-6.68%1.47B
-3.08%1.49B
0.25%1.57B
-0.10%1.57B
0.73%1.57B
-1.96%1.53B
0.22%1.57B
0.36%1.57B
-1.16%1.56B
-3.32%1.56B
Total assets
-13.72%1.74B
-9.38%1.79B
-9.97%1.88B
-8.65%1.91B
-5.52%2.01B
-7.71%1.98B
-0.00%2.09B
-2.76%2.09B
-0.83%2.13B
-6.42%2.14B
Liabilities
Current liabilities
Short term loan
-4.83%153.55M
-2.95%166.05M
-17.23%166.57M
-28.49%124.8M
-4.98%161.34M
22.30%171.08M
139.57%201.24M
66.20%174.51M
60.77%169.8M
5.01%139.89M
Notes payable and accounts payable
18.60%60.78M
-20.44%52.71M
-28.22%52.82M
-34.49%49.5M
-19.70%51.25M
-15.08%66.26M
-26.31%73.58M
-27.92%75.56M
9.11%63.82M
35.92%78.02M
-Notes payable
----
----
----
----
----
----
-85.55%5.78M
-85.55%5.78M
----
----
-Accounts payable
18.60%60.78M
-20.44%52.71M
-22.10%52.82M
-29.06%49.5M
-19.70%51.25M
-15.08%66.26M
13.29%67.8M
7.64%69.78M
9.11%63.82M
35.92%78.02M
Contract liabilities
-51.68%14.52M
-41.88%24.53M
49.87%16.73M
42.90%36.35M
108.35%30.05M
291.23%42.21M
-20.23%11.16M
42.52%25.43M
-39.57%14.42M
-88.72%10.79M
Advance receipts
398.27%1.2M
-45.92%262.8K
64.31%394.35K
204.61%731.06K
1,851.22%240K
6,142.66%485.93K
1,034.86%240K
797.87%240K
48.01%12.3K
-33.33%7.78K
Salaries payable
-6.47%7.41M
-23.18%8.59M
-5.59%7.6M
-5.41%7.73M
-8.54%7.92M
0.84%11.18M
-8.29%8.05M
-4.72%8.17M
-18.50%8.66M
0.16%11.09M
Taxs payable
49.86%12.93M
36.86%15.62M
-14.20%13.68M
8.44%10.68M
-65.23%8.63M
-64.55%11.42M
-4.53%15.95M
-34.08%9.85M
80.74%24.81M
28.85%32.2M
Other payable (including interest and dividends)
24.83%208.98M
127.04%230.79M
116.63%159.38M
107.14%154.78M
138.55%167.41M
41.99%101.65M
18.08%73.57M
23.64%74.72M
0.40%70.18M
0.32%71.59M
-Other payable
----
127.04%230.79M
----
107.14%154.78M
----
41.99%101.65M
----
23.64%74.72M
----
0.32%71.59M
Non current liabilities due within one year
-25.38%81.24M
-26.85%81.17M
-25.42%67.45M
16.47%88.45M
189.41%108.88M
201.81%110.97M
29.74%90.44M
8.94%75.94M
-56.51%37.62M
-65.65%36.77M
Other current liabilities
-51.74%1.88M
-31.36%3.76M
50.15%2.17M
47.82%4.72M
121.62%3.9M
296.33%5.48M
-20.09%1.45M
38.12%3.19M
-43.20%1.76M
-63.05%1.38M
Total current liabilities
0.53%542.49M
12.05%583.49M
2.34%486.8M
6.73%477.74M
37.98%539.62M
36.41%520.74M
33.18%475.69M
16.67%447.63M
5.17%391.09M
-24.33%381.74M
Current liabilities
Long term loan
-23.94%181.82M
-13.42%181.82M
-5.28%233.07M
-12.73%233.07M
-25.77%239.04M
-35.38%210M
-19.36%246.06M
-12.91%267.06M
-0.09%322.05M
-5.21%324.98M
Deferred tax liabilities
-4.78%32.87M
-4.77%32.93M
10.23%36.53M
3.38%34.46M
1.40%34.52M
2.13%34.58M
-5.71%33.14M
-4.69%33.33M
-2.15%34.04M
-2.16%33.86M
Long term deferred income
4.48%53.15M
4.39%53.89M
8.33%54.64M
8.34%55.39M
7.11%50.87M
7.15%51.63M
3.22%50.44M
3.14%51.13M
-5.56%47.49M
-5.54%48.18M
Lease liabilities
-5.22%17.85M
-5.32%17.66M
--19.19M
--19.01M
--18.83M
--18.65M
----
----
----
----
Total non current liabilities
-16.77%285.69M
-9.07%286.3M
4.18%343.44M
-2.73%341.93M
-14.95%343.26M
-22.64%314.85M
-15.29%329.64M
-10.14%351.52M
-0.94%403.58M
-5.00%407.01M
Total liabilities
-6.20%828.17M
4.09%869.79M
3.09%830.24M
2.57%819.67M
11.10%882.88M
5.94%835.59M
7.90%805.33M
3.13%799.15M
1.98%794.66M
-15.46%788.76M
Shareholders equity
Paid-in capital
0.00%455.12M
0.00%455.12M
0.00%455.12M
1.14%455.12M
1.14%455.12M
1.14%455.12M
1.14%455.12M
0.00%450M
0.00%450M
0.00%450M
Capital reserve funds
0.00%842.99M
0.00%842.99M
-1.97%842.99M
-0.48%842.99M
0.07%842.99M
0.78%842.99M
3.89%859.94M
3.43%847.08M
2.86%842.36M
2.14%836.49M
Surplus reserve funds
0.00%54.94M
0.00%54.94M
0.00%54.94M
0.00%54.94M
0.00%54.94M
0.00%54.94M
4.00%54.94M
4.00%54.94M
4.00%54.94M
4.00%54.94M
Retained profit
-77.67%-531.17M
-79.56%-519.42M
-125.15%-385.89M
-129.64%-343.36M
-214.16%-298.97M
-291.83%-289.28M
-118.26%-171.39M
-258.03%-149.52M
-123.08%-95.16M
-27.13%-73.83M
Other composite income
27.68%66.05M
27.71%66.07M
11.84%58.13M
-0.51%51.72M
-0.49%51.73M
-0.49%51.73M
-0.94%51.98M
-0.92%51.98M
-0.92%51.98M
-0.92%51.98M
Shareholders equity without minority interests
-19.70%887.94M
-19.35%899.71M
-18.02%1.03B
-15.39%1.06B
-15.21%1.11B
-15.47%1.12B
-4.13%1.25B
-5.85%1.25B
-2.06%1.3B
0.26%1.32B
Minority interests
-14.96%21.12M
-15.32%21.51M
-24.64%23.88M
-24.67%24.37M
-23.44%24.83M
-23.65%25.4M
-13.94%31.69M
-14.28%32.35M
-15.06%32.44M
-15.41%33.26M
Total shareholder equity
-19.60%909.06M
-19.26%921.22M
-18.18%1.05B
-15.62%1.09B
-15.41%1.13B
-15.67%1.14B
-4.40%1.28B
-6.09%1.29B
-2.43%1.34B
-0.20%1.35B
Total liabilityies and equity
-13.72%1.74B
-9.38%1.79B
-9.97%1.88B
-8.65%1.91B
-5.52%2.01B
-7.71%1.98B
-0.00%2.09B
-2.76%2.09B
-0.83%2.13B
-6.42%2.14B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds -81.42%17.27M-47.21%59.75M-85.48%17.95M-52.89%47.46M-18.66%92.97M-21.62%113.19M18.14%123.63M-41.29%100.73M-36.34%114.29M-46.48%144.4M
Notes receivable and accounts receivable -32.44%41.88M-35.79%44.16M-23.27%49.71M-13.39%60.95M-43.47%61.98M-36.07%68.77M40.89%64.78M16.52%70.37M94.07%109.66M47.09%107.58M
-Notes receivable -80.87%1.35M1,092.66%7.39M175.71%3.11M3.81%6.27M-21.32%7.05M-83.50%620.03K253.53%1.13M-31.21%6.04M39.85%8.96M87.04%3.76M
-Accounts receivable -26.22%40.53M-46.05%36.77M-26.79%46.6M-15.00%54.68M-45.45%54.93M-34.36%68.15M39.41%63.66M24.63%64.33M101.01%100.69M45.96%103.82M
Other receivables (including interest and dividends) -84.44%10.72M-72.44%11.63M-54.89%28.27M-51.82%27.87M8.35%68.86M-23.89%42.21M-4.92%62.65M0.94%57.84M-6.27%63.56M-18.00%55.46M
-Other receivable -----72.44%11.63M-------------23.89%42.21M----0.94%57.84M-----18.00%55.46M
Advance payment 3.28%36.55M12.74%26.85M-2.49%42.99M-17.33%28.8M-5.95%35.39M-15.26%23.81M17.90%44.09M-12.65%34.84M-3.23%37.63M-68.32%28.1M
Inventories -8.61%160.33M-14.53%160.12M-24.62%166.89M-31.55%167.85M-27.17%175.43M-20.77%187.33M-16.17%221.41M-1.15%245.22M8.16%240.87M38.75%236.43M
Other current assets -61.35%2.06M-73.66%1.97M-22.95%4.46M-45.70%3.38M74.75%5.33M40.25%7.47M-25.12%5.78M133.24%6.23M-1.91%3.05M593.00%5.33M
Total current assets -38.90%268.81M-31.24%304.48M-40.60%310.26M-34.73%336.3M-22.68%439.97M-23.30%442.78M-0.65%522.35M-11.15%515.22M0.09%569.05M-13.90%577.3M
Non Current assets
Other equity investment 0.00%4.97M0.00%4.97M-6.16%4.97M-6.16%4.97M-6.16%4.97M-6.16%4.97M-10.87%5.3M-10.87%5.3M-10.87%5.3M-10.87%5.3M
Investment real estate 128.76%556.07M169.58%556.07M149.93%564.86M7.56%243.08M7.56%243.08M-8.73%206.27M-4.88%226.01M-4.88%226.01M-4.88%226.01M-4.88%226.01M
Fixed assets -----31.46%680.02M------------17.88%992.13M-----1.81%847.79M-----5.53%841.67M
Fixed assets liquidation --------------------207.16%85.69K------27.9K------27.9K
Constru in process ----49.61%18M-------------91.74%12.03M----63.55%146.29M----144.37%145.62M
Productive biological assets ------------------17.18K------21.78K--17.16K--------
Intangible assets -58.29%61.6M-54.45%63.71M-34.49%101.85M-7.61%145.83M-6.55%147.7M-12.77%139.86M-3.48%155.47M-3.20%157.84M-4.36%158.06M-4.31%160.33M
Development expenditure -39.03%31.07M-39.03%31.07M18.66%55.6M14.27%53.54M16.71%50.97M16.79%50.97M22.86%46.86M22.86%46.86M14.50%43.67M16.85%43.64M
Goodwill -38.52%8.3M-38.52%8.3M-34.55%13.5M-34.55%13.5M-32.68%13.5M-32.68%13.5M9.19%20.63M9.19%20.63M6.14%20.05M6.14%20.05M
Long deferred expense -18.81%25.06M-7.83%24.79M-11.08%26.32M-11.77%28.54M-18.84%30.87M-28.04%26.9M-16.97%29.6M-13.87%32.35M-1.96%38.03M-1.26%37.38M
Deferred tax assets 26.77%64.93M37.14%70.74M9.79%65.15M-1.84%56.97M18.10%51.22M2.48%51.59M35.55%59.35M17.97%58.04M-8.96%43.37M5.08%50.34M
Usufruct assets -5.41%16.91M-5.33%17.15M--17.39M--17.63M--17.87M--18.11M----------------
Other non current assets -24.69%11.4M-32.43%11.68M-46.77%14.34M-33.06%19.82M-73.48%15.14M-49.06%17.29M-30.70%26.95M-52.19%29.61M-37.08%57.09M-70.32%33.95M
Total non current assets -6.68%1.47B-3.08%1.49B0.25%1.57B-0.10%1.57B0.73%1.57B-1.96%1.53B0.22%1.57B0.36%1.57B-1.16%1.56B-3.32%1.56B
Total assets -13.72%1.74B-9.38%1.79B-9.97%1.88B-8.65%1.91B-5.52%2.01B-7.71%1.98B-0.00%2.09B-2.76%2.09B-0.83%2.13B-6.42%2.14B
Liabilities
Current liabilities
Short term loan -4.83%153.55M-2.95%166.05M-17.23%166.57M-28.49%124.8M-4.98%161.34M22.30%171.08M139.57%201.24M66.20%174.51M60.77%169.8M5.01%139.89M
Notes payable and accounts payable 18.60%60.78M-20.44%52.71M-28.22%52.82M-34.49%49.5M-19.70%51.25M-15.08%66.26M-26.31%73.58M-27.92%75.56M9.11%63.82M35.92%78.02M
-Notes payable -------------------------85.55%5.78M-85.55%5.78M--------
-Accounts payable 18.60%60.78M-20.44%52.71M-22.10%52.82M-29.06%49.5M-19.70%51.25M-15.08%66.26M13.29%67.8M7.64%69.78M9.11%63.82M35.92%78.02M
Contract liabilities -51.68%14.52M-41.88%24.53M49.87%16.73M42.90%36.35M108.35%30.05M291.23%42.21M-20.23%11.16M42.52%25.43M-39.57%14.42M-88.72%10.79M
Advance receipts 398.27%1.2M-45.92%262.8K64.31%394.35K204.61%731.06K1,851.22%240K6,142.66%485.93K1,034.86%240K797.87%240K48.01%12.3K-33.33%7.78K
Salaries payable -6.47%7.41M-23.18%8.59M-5.59%7.6M-5.41%7.73M-8.54%7.92M0.84%11.18M-8.29%8.05M-4.72%8.17M-18.50%8.66M0.16%11.09M
Taxs payable 49.86%12.93M36.86%15.62M-14.20%13.68M8.44%10.68M-65.23%8.63M-64.55%11.42M-4.53%15.95M-34.08%9.85M80.74%24.81M28.85%32.2M
Other payable (including interest and dividends) 24.83%208.98M127.04%230.79M116.63%159.38M107.14%154.78M138.55%167.41M41.99%101.65M18.08%73.57M23.64%74.72M0.40%70.18M0.32%71.59M
-Other payable ----127.04%230.79M----107.14%154.78M----41.99%101.65M----23.64%74.72M----0.32%71.59M
Non current liabilities due within one year -25.38%81.24M-26.85%81.17M-25.42%67.45M16.47%88.45M189.41%108.88M201.81%110.97M29.74%90.44M8.94%75.94M-56.51%37.62M-65.65%36.77M
Other current liabilities -51.74%1.88M-31.36%3.76M50.15%2.17M47.82%4.72M121.62%3.9M296.33%5.48M-20.09%1.45M38.12%3.19M-43.20%1.76M-63.05%1.38M
Total current liabilities 0.53%542.49M12.05%583.49M2.34%486.8M6.73%477.74M37.98%539.62M36.41%520.74M33.18%475.69M16.67%447.63M5.17%391.09M-24.33%381.74M
Current liabilities
Long term loan -23.94%181.82M-13.42%181.82M-5.28%233.07M-12.73%233.07M-25.77%239.04M-35.38%210M-19.36%246.06M-12.91%267.06M-0.09%322.05M-5.21%324.98M
Deferred tax liabilities -4.78%32.87M-4.77%32.93M10.23%36.53M3.38%34.46M1.40%34.52M2.13%34.58M-5.71%33.14M-4.69%33.33M-2.15%34.04M-2.16%33.86M
Long term deferred income 4.48%53.15M4.39%53.89M8.33%54.64M8.34%55.39M7.11%50.87M7.15%51.63M3.22%50.44M3.14%51.13M-5.56%47.49M-5.54%48.18M
Lease liabilities -5.22%17.85M-5.32%17.66M--19.19M--19.01M--18.83M--18.65M----------------
Total non current liabilities -16.77%285.69M-9.07%286.3M4.18%343.44M-2.73%341.93M-14.95%343.26M-22.64%314.85M-15.29%329.64M-10.14%351.52M-0.94%403.58M-5.00%407.01M
Total liabilities -6.20%828.17M4.09%869.79M3.09%830.24M2.57%819.67M11.10%882.88M5.94%835.59M7.90%805.33M3.13%799.15M1.98%794.66M-15.46%788.76M
Shareholders equity
Paid-in capital 0.00%455.12M0.00%455.12M0.00%455.12M1.14%455.12M1.14%455.12M1.14%455.12M1.14%455.12M0.00%450M0.00%450M0.00%450M
Capital reserve funds 0.00%842.99M0.00%842.99M-1.97%842.99M-0.48%842.99M0.07%842.99M0.78%842.99M3.89%859.94M3.43%847.08M2.86%842.36M2.14%836.49M
Surplus reserve funds 0.00%54.94M0.00%54.94M0.00%54.94M0.00%54.94M0.00%54.94M0.00%54.94M4.00%54.94M4.00%54.94M4.00%54.94M4.00%54.94M
Retained profit -77.67%-531.17M-79.56%-519.42M-125.15%-385.89M-129.64%-343.36M-214.16%-298.97M-291.83%-289.28M-118.26%-171.39M-258.03%-149.52M-123.08%-95.16M-27.13%-73.83M
Other composite income 27.68%66.05M27.71%66.07M11.84%58.13M-0.51%51.72M-0.49%51.73M-0.49%51.73M-0.94%51.98M-0.92%51.98M-0.92%51.98M-0.92%51.98M
Shareholders equity without minority interests -19.70%887.94M-19.35%899.71M-18.02%1.03B-15.39%1.06B-15.21%1.11B-15.47%1.12B-4.13%1.25B-5.85%1.25B-2.06%1.3B0.26%1.32B
Minority interests -14.96%21.12M-15.32%21.51M-24.64%23.88M-24.67%24.37M-23.44%24.83M-23.65%25.4M-13.94%31.69M-14.28%32.35M-15.06%32.44M-15.41%33.26M
Total shareholder equity -19.60%909.06M-19.26%921.22M-18.18%1.05B-15.62%1.09B-15.41%1.13B-15.67%1.14B-4.40%1.28B-6.09%1.29B-2.43%1.34B-0.20%1.35B
Total liabilityies and equity -13.72%1.74B-9.38%1.79B-9.97%1.88B-8.65%1.91B-5.52%2.01B-7.71%1.98B-0.00%2.09B-2.76%2.09B-0.83%2.13B-6.42%2.14B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion with explanatory notes------Unqualified opinion------Unqualified opinion
Auditor --Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)------Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)------Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More